MORGAN STANLEY - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 79 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,094,820
-61.0%
287,354
-51.5%
0.00%
Q1 2024$2,808,020
+10.0%
592,410
-0.9%
0.00%
Q4 2023$2,551,720
+237.8%
597,592
+144.4%
0.00%
Q3 2023$755,411
-14.1%
244,470
+25.2%
0.00%
Q2 2023$878,968
+8.9%
195,326
+37.9%
0.00%
Q1 2023$807,474
+48.6%
141,662
+57.5%
0.00%
Q4 2022$543,291
-53.8%
89,949
-49.4%
0.00%
Q3 2022$1,175,000
-53.2%
177,788
-63.0%
0.00%
Q2 2022$2,510,000
-33.4%
480,788
-12.0%
0.00%
-100.0%
Q1 2022$3,770,000
-64.2%
546,475
-35.4%
0.00%0.0%
Q4 2021$10,528,000
-55.5%
845,714
+11.8%
0.00%
-66.7%
Q3 2021$23,650,000
+525.2%
756,787
+472.6%
0.00%
Q2 2021$3,783,000
+262.4%
132,165
+449.0%
0.00%
Q1 2021$1,044,000
-46.2%
24,074
-11.3%
0.00%
Q4 2020$1,941,000
+390.2%
27,128
+106.2%
0.00%
Q3 2020$396,00013,1550.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,039,691$66,362,0001.23%
Baker Brothers Advisors 10,123,824$66,918,0000.44%
HHLR ADVISORS, LTD. 583,333$3,856,0000.10%
CAXTON ASSOCIATES LP 85,992$568,0000.08%
Virtus ETF Advisers LLC 24,180$160,0000.06%
GSA CAPITAL PARTNERS LLP 54,173$358,0000.05%
DENALI ADVISORS LLC 8,200$54,0000.03%
PDT Partners, LLC 12,641$84,0000.01%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2,402,595$15,881,153,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 36,949$244,0000.01%
View complete list of PRELUDE THERAPEUTICS INC shareholders